Search results

Narrow your search

Result types

Showing 161 - 170 of 276 for "Weerawong C&P" with applied filters

News & Analysis

Revisiting 101 rule of Transfer Pricing in Indonesia

29 May 2023 by ABNR - Indonesia: Freddy Karyadi, Anastasia Irawati

As one of the designated Key Partners of the OECD, Indonesia has implemented some of the OECD’s Action Plans into its prevailing laws and regulations, including Action 8-10 concerning Transfer Pricing and Action 13 concerning Country-by-country Reporting.

News & Analysis

Patenting Molecular Diagnostics

17 May 2023 by LexOrbis - DPS Parmar

The patent eligibility in every jurisdiction differs in content and form. It perhaps finds its justification in the stage of development the country is placed in relation to inventions of new technology or its adoption by the state technology groups.

News & Analysis

DHC on irrational reasoning and requirements in patent refusal orders

04 May 2023 by Rahul Chaudhry & Partners - Madhuri Gupta, Senior Associate, Patents team

In a recent Judgement, the Delhi High Court (“Court”) decided on an appeal filed by Microsoft Corporation to set aside the decision of Controller General of Patents and Designs (“Controller”) dated 05th March 2012 refusing the grant of Indian patent application 487/DELNP/2006 (“subject patent”) under Section 15 of the Patents Act.

News & Analysis

Listing in Hong Kong of a World Bank catastrophe bond

21 April 2023 by LC Lawyers - Rossana Chu (Managing partner)

Hong Kong has taken another step in developing the city as a leading international risk management center. On 28 March 2023, a US$350 million World Bank catastrophe bond was listed on the Hong Kong Stock Exchange .

News & Analysis

Product Hopping and Ever-Greening of Patents in India

20 April 2023 by LexOrbis - Arun Kumar (Managing associate)

The Indian pharmaceutical market is one of the largest markets in the globe, both in terms of production and consumption. Several changes have been made to the patent and competition law due to the increasing challenges in the pharmaceutical market that directly impact the profit margin of pharmaceutical manufacturers. To increase these margins, pharmaceutical product manufacturing firms employ a variety of strategies. This article investigates the concept of “product hopping” and compares it with the practice of patent evergreening.

News & Analysis
Image

LAWYER OF THE MONTH - APRIL 2023

19 April 2023 by asialaw

asialaw's Lawyer of the Month for April 2023 is...

News & Analysis

Doing Business in the Philippines

04 April 2023 by SyCip Salazar Hernandez & Gatmaitan

This guide, which focuses on how foreign corporations can set up a legal presence in the Philippines, was first published in 2015, when our firm celebrated its 70th anniversary, and this most recent update was prepared in connection with our 78th anniversary celebrations.

News & Analysis

SyCip Salazar Hernandez & Gatmaitan - Banking bulletin

30 March 2023 by SyCip Salazar Hernandez & Gatmaitan

SyCipLaw's Banking, Finance & Securities Department's Banking Bulletin for March 2023 features the latest issuances from the Bangko Sentral ng Pilipinas (BSP) and the NAtional Provacy Commission (NPC).

News & Analysis

Enforcement of Store Layout Trademarks in India – An uphill battle for brand owners

28 March 2023 by Rahul Chaudhry & Partners - Farhaan Rizvi

A visually appealing store is a crucial asset for any business aiming to provide a consistent quality of goods and services across its stores . These stores featuring a distinct theme design commonly seen on their signage, wall arts, overall décor etc. not only reflects a cohesive brand imagery of the business but also create a lasting impression on the customers, strengthening their brand recall value.

News & Analysis

Overview of Private Investment to Indonesia’s New Capital City: Ibu Kota Nusantara (IKN)

27 March 2023 by Makarim & Taira S - Indonesia

The Government of Indonesia moves forward the development of Indonesia’s new capital city, namely Ibu Kota Nusantara (“IKN”) by issuing several underlying regulations to date in effort to encourage the participation of private sector in accelerating the infrastructure development of the IKN. One of them being the groundworks to implement the public-private partnerships in such development. With a total cost estimate of more than IDR460 trillion (or approximately USD30 billion), the five-stages development of IKN is targeted to be 80% funded from non-State Budget and therefore can be expected to attract private investors participation in it. This advisory provides an overview of the funding schemes and private sector participation in the development of IKN.